Latest filing published 16 Dec 2016 for Valeant Pharmaceuticals International, Inc., €1.3M.
William A. Ackman is a declared insider of Valeant Pharmaceuticals International, Inc., with filings sourced from SEDI. We count 2 filings, every one of them for a trade on 12 December 2016.
Every open-market trade on record is a sale: 2 sales worth €37.3M.
The latest filing, published on 16 December 2016, reports an open-market sale of €1.3M in Valeant Pharmaceuticals International, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations